February 8, 2021
Izzo NJ et al. Alzheimer’s Dement 2021;1–18.
Preclinical and clinical biomarker studies of CT1812:
A novel approach to Alzheimer’s disease modification
Download publication
You might also be interested by
Webcasts & Webinars
Precision Oncology Approaches: Using Proteomics to Build Next-Gen Diagnostic Solutions
May 2, 2023
Proteomics/Mass Spectrometry
More infoPosters
Analytical characterization of a multiplex panel measuring 45 cytokines by proximity extension assay in plasma from subjects with NSCLC
April 17, 2023
Proteomics/Mass Spectrometry
More info